{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:14:09Z","timestamp":1786115649419,"version":"build-2736575974"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Papillary thyroid carcinoma (PTC) predominantly affects women, particularly during the reproductive years, suggesting that reproductive factors may influence not only tumor occurrence but also metastatic behavior. However, evidence regarding the association between reproductive history and lymph node metastasis (LNM) in women with established PTC remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of 1,828 women with pathologically confirmed PTC who underwent initial surgery. The primary outcome was any cervical lymph node metastasis (LNM). Secondary outcomes included isolated central lymph node metastasis (CLNM) and combined central and lateral lymph node metastasis (CLNM+LLNM). Multivariable logistic regression models were used to evaluate the associations between reproductive history, gravidity, parity, and abortion history and nodal outcomes. Reproductive variables were analyzed in separate models to reduce collinearity. Sensitivity and subgroup analyses were performed to examine the stability of the observed associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Cervical LNM was identified in 903 patients (49.4%). In the primary adjusted model, ever pregnancy was associated with lower odds of any LNM (adjusted OR 0.420, 95% CI 0.276-0.640;\n                      <jats:italic>P&amp;lt;0.001<\/jats:italic>\n                      ). Compared with nulligravid women, the adjusted ORs for any LNM were 0.404 (95% CI 0.260-0.628), 0.480 (95% CI 0.306-0.751), and 0.356 (95% CI 0.224-0.567) for women with 1, 2, and \u22653 pregnancies, respectively (\n                      <jats:italic>P<\/jats:italic>\n                      for trend &amp;lt;0.001). Similar inverse associations were observed for isolated CLNM and CLNM+LLNM. However, the category-specific estimates were not strictly monotonic, suggesting a threshold-like rather than a linear dose-response pattern. Similar inverse associations were observed for isolated CLNM and CLNM+LLNM in the primary models. In sensitivity analyses, the associations generally remained directionally inverse but were attenuated in some analyses, including models using flexible adjustment for continuous age. Analyses involving lateral disease were interpreted cautiously because lateral neck dissection was not performed uniformly across the cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In women with PTC, ever pregnancy was associated with lower odds of cervical LNM, particularly for central compartment disease. This association appeared to be more closely related to ever having been pregnant than to a linear increase in gravidity or parity. Reproductive history may provide supplementary context for nodal risk assessment, but it should not replace established clinicopathological factors or independently alter surgical decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1856799","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:25:10Z","timestamp":1785990310000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of gravidity, parity, and abortion history with nodal metastasis in women with papillary thyroid carcinoma: a retrospective cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Kai","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Head and Neck Surgery, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqiang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Radiological Intervention, The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(20)30372-7","article-title":"Thyroid cancer in the USA: current trends and outstanding questions","volume":"9","author":"Davies","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s12889-021-10635-w","article-title":"Trend dynamics of thyroid cancer incidence among China and the U.S. adult population from 1990 to 2017: a joinpoint and age-period-cohort analysis","volume":"21","author":"Cui","year":"2021","journal-title":"BMC Public Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012-0011","article-title":"Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature","volume":"22","author":"Giordano","year":"2012","journal-title":"Thyroid"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-017-4158-5","article-title":"Macrometastasis in papillary thyroid cancer patients is associated with higher recurrence in lateral neck nodes","volume":"42","author":"Kim","year":"2018","journal-title":"World J Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10144","article-title":"Risk factors for recurrence in patients with papillary thyroid carcinoma undergoing modified radical neck dissection","volume":"103","author":"Lee","year":"2016","journal-title":"Br J Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00265","article-title":"Risk factors for lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis","volume":"11","author":"Mao","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-015-0546-z","article-title":"Menstrual and reproductive history and use of exogenous sex hormones and risk of thyroid cancer among women: a meta-analysis of prospective studies","volume":"26","author":"Caini","year":"2015","journal-title":"Cancer Causes Control"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/103515","article-title":"Reproductive factors but not hormonal factors associated with thyroid cancer risk: a systematic review and meta-analysis","volume":"2015","author":"Cao","year":"2015","journal-title":"BioMed Res Int"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a010276","article-title":"Reproductive factors and risk of papillary thyroid cancer in women","volume":"151","author":"Rossing","year":"2000","journal-title":"Am J Epidemiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2011.05.009","article-title":"Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study","volume":"35","author":"Schonfeld","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2022.10.001","article-title":"A protective factor against lymph node metastasis of papillary thyroid cancer: female gender","volume":"50","author":"Shi","year":"2023","journal-title":"Auris Nasus Larynx"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-024-02309-2","article-title":"Distinct risk factors of lateral lymph node metastasis in patients with papillary thyroid cancer based on age stratification","volume":"24","author":"Cai","year":"2024","journal-title":"BMC Surg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12902-024-01576-7","article-title":"Predictive value of jugulo-omohyoid lymph nodes in lateral lymph node metastasis of papillary thyroid cancer","volume":"24","author":"Cai","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000001797","article-title":"Potential pitfalls of reporting and bias in observational studies with propensity score analysis assessing a surgical procedure: a methodological systematic review","volume":"265","author":"Lonjon","year":"2017","journal-title":"Ann Surg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.21037\/gs-20-482","article-title":"Predictive factors of lateral lymph node metastasis in conventional papillary thyroid carcinoma","volume":"9","author":"Song","year":"2020","journal-title":"Gland Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/0194599820966995","article-title":"Association between age and nodal metastasis in papillary thyroid carcinoma","volume":"165","author":"Shukla","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.02.011","article-title":"Patient's age with papillary thyroid cancer: Is it a key factor for cervical lymph node metastasis","volume":"49","author":"Wang","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.capr-13-0367","article-title":"Benign breast and gynecologic conditions, reproductive and hormonal factors, and risk of thyroid cancer","volume":"7","author":"Braganza","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2013.0527","article-title":"Papillary thyroid microcarcinoma might progress during pregnancy","volume":"24","author":"Shindo","year":"2014","journal-title":"Thyroid"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0393","article-title":"Effects of pregnancy on papillary microcarcinomas of the thyroid re-evaluated in the entire patient series at Kuma Hospital","volume":"26","author":"Ito","year":"2016","journal-title":"Thyroid"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2184.2007.00471.x","article-title":"Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway","volume":"40","author":"Zeng","year":"2007","journal-title":"Cell Prolif"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.916804","article-title":"The isoforms of estrogen receptor alpha and beta in thyroid cancer","volume":"12","author":"Gong","year":"2022","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-383","article-title":"Differential expression patterns and clinical significance of estrogen receptor-\u03b1 and \u03b2 in papillary thyroid carcinoma","volume":"14","author":"Huang","year":"2014","journal-title":"BMC Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1530\/eje-15-0054","article-title":"Impact of estrogen and progesterone receptor expression on the clinical and molecular features of papillary thyroid cancer","volume":"173","author":"Vannucchi","year":"2015","journal-title":"Eur J Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1856799\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:25:11Z","timestamp":1785990311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1856799\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":27,"alternative-id":["10.3389\/fendo.2026.1856799"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1856799","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"article-number":"1856799"}}